All posts by: Michael Zand

About Michael Zand

Researchers design process to better understand how advanced melanoma adapts to immunotherapy – Science Daily

Continue reading

2017-05-13 NEWS

Researchers design process to better understand how advanced melanoma adapts to immunotherapy
Science Daily
The findings lay the groundwork for developing new and improved combination therapies for patients who are resistant to stand-alone immunotherapy treatments. Pembrolizumab (marketed as Keytruda) works by signaling the patient’s immune system to …

Continue reading

2017-05-13 NEWS

University of Bristol

Two new start-up plans win BrisSynBio’s first synthetic biology entrepreneurship competition
University of Bristol
17 synthetic biology researchers received training and coaching on how to set up a biotech company using synthetic biology as part of the BrisSynBio 4-Day MBA ‘More Business Acumen’ course – developed by SynbiCITE. At the climax of the course, …